DFI USA, LLC
USPTO PatentsView assignee record - 5 granted patents across 4 technology areas, recorded in grant years 2018–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07C (Acyclic OR Carbocyclic Compounds).
The verdict
According to USPTO PatentsView, DFI ranks #46,141 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 4 technology areas.
- #46,141
- of 49,997 US assignees by volume
- 32nd percentile
- by Innovation Score (29.9/100)
- 16.6
- avg claims per patent
- +50%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R46141 · US Corporation #46,141 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #46,141/49,997
- PHOTO-FINISH Deutsches Zentrum…
- CPC-NARROW C07C · 4 areas
- INNOV-THIN 29.9/100
- CLAIMS-RICH 16.6 claims/avg
- TYPE-USCORP US Corporation
- VEL-SURGE +50% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Deutsches Zentrum FUR Neurodegenrative Erkankung (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How DFI’s 29.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around DFI
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- DFI USA · this assignee 30
DFI USA · this assignee
30 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows DFI's Innovation Score is 29.9/100 (32nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for DFI?
Each dot is one of DFI’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). DFI’s own 16.6 claims/patent is ABOVE the 8.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where DFI's grants concentrate
DFI USA, LLC is a focused PatentsView assignee: 4 CPC subclasses with 80% of grants classified under C07C (Acyclic OR Carbocyclic Compounds). By volume, DFI sits between Deutsches Zentrum FUR Neurodegenrative Erkankung and Diageo Ireland.
DFI's three-year grant acceleration
DFI USA, LLC shows 2 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at DFI's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Deutsches Zentrum…
Deutsches Zentrum FUR Neurodegenrative Erkankung
5 patents
- Deuve Photonics
Deuve Photonics, Inc.
5 patents
- Devilbiss Healthc…
Devilbiss Healthcare LLC
5 patents
- Dexos Drinks
Dexos Drinks Limited
5 patents
- Dgel Electrosystem
Dgel Electrosystem Inc.
5 patents
- DGM Creations
DGM Creations LLC
5 patents
- DH
DH Co., Ltd.
5 patents
- Diageo Ireland
Diageo Ireland
5 patents
- DFI USA ◀
DFI USA, LLC
5 patents
What this shows DFI holds 5 patents at rank #46,076, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near DFI
By rank, the assignees closest to #46,076 in granted patent volume.
- Deutsches Zentrum FUR Neurodegenrative Erkankung #46,072 · 5 patents
- Deuve Photonics, Inc. #46,073 · 5 patents
- Devilbiss Healthcare LLC #46,074 · 5 patents
- Dexos Drinks Limited #46,075 · 5 patents
- Dgel Electrosystem Inc. #46,077 · 5 patents
- DGM Creations LLC #46,078 · 5 patents
- DH Co., Ltd. #46,079 · 5 patents
- Diageo Ireland #46,080 · 5 patents
Leaders in C07C (Acyclic OR Carbocyclic Compounds)
Other assignees with the most granted patents in DFI's primary technology class.
DFI's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
30 32nd percentile higher than 32% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 20.0% |
| 2019 | 1 | 20.0% |
| 2021 | 1 | 20.0% |
| 2023 | 1 | 20.0% |
| 2024 | 1 | 20.0% |
Which technologies does DFI USA, LLC patent most?
Top 4 of 4 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
DFI USA, LLC's patent record in context - here's where to go next.
- DFI USA, LLC's lead technology class is C07C (Acyclic OR Carbocyclic Compounds), 80% of its portfolio - see every assignee active in that class. Explore C07C
- Ranked #46,141 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare DFI USA, LLC against Deutsches Zentrum FUR Neurodegenrative Erkankung, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 29.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.